Ayurcann Holdings Corp.
AYURF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | -0.00 | -0.01 | 0.00 |
| FCF Yield | -13.38% | 16.51% | 6.73% | 12.77% |
| EV / EBITDA | -13.85 | -1.56 | -31.62 | 13.31 |
| Quality | ||||
| ROIC | 10.42% | 32.88% | -6.52% | 1.12% |
| Gross Margin | 25.28% | 19.40% | 34.12% | 43.61% |
| Cash Conversion Ratio | 0.97 | -0.31 | -0.64 | -5.24 |
| Growth | ||||
| Revenue 3-Year CAGR | 45.14% | 44.03% | 42.79% | 32.18% |
| Free Cash Flow Growth | -235.33% | 141.26% | -43.06% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.30 | 0.56 | -8.01 | -0.95 |
| Interest Coverage | -6.52 | -27.29 | -2.21 | 0.39 |
| Efficiency | ||||
| Inventory Turnover | 1.48 | 1.90 | 0.83 | 0.68 |
| Cash Conversion Cycle | -98.75 | 38.79 | 9.83 | 50.38 |